Benzinga | Aug 4, 2020 04:57PM EDT

Aerpio Pharmaceuticals Announces A Second Clinical Trial With Funding From MTEC To Evaluate Razuprotafib For The Prevention And Treatment Of ARDS In Patients With Moderate To Severe Coronavirus